The introduction of the WHO FRAX® algorithms has facilitated the assessment of fracture risk on the basis of fracture probability. FRAX® integrates the influence of several well validated risk factors for fracture with or without the use of BMD. Its use in fracture risk prediction poses challenges for patient assessment, the development of practice guidelines, the evaluation of drug efficacy and reimbursement, as well as for health economics which are the topics outlined in this review.
Keywords:
FRAX®; Fracture probability; Risk assessment; Cost-effectiveness; Efficacy